# Effect of Prolonged (72 Hour) Glucagon Administration on Energy Expenditure in Healthy Obese Subjects

> **NCT03139305** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **AdventHealth Translational Research Institute** · enrollment: 30 (estimated)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Glucagon
- **DRUG:** Glucagon
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03139305
- **Lead sponsor:** AdventHealth Translational Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2017-10-24
- **Primary completion:** 2018-02-14
- **Final completion:** 2027-02
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03139305

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03139305, "Effect of Prolonged (72 Hour) Glucagon Administration on Energy Expenditure in Healthy Obese Subjects". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03139305. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*